Rocket Lab's Insider Sales Tell a Familiar Story, Even as the Backlog Hits a Record

Rocket Lab's record backlog and revenue growth overshadow routine insider stock sales, but analysts remain split on valuation.

The most telling detail about Rocket Lab's current moment isn't the company's soaring order book or its ambitious $8 billion takeover plan. It's the fact that four senior executives sold stock on the same day — and the market barely blinked.

Those sales, which took place on August 24, saw Chief Operating Officer Frank Klein offload 45,692 shares worth roughly $3.18 million, while President Marvin Bradford Clevenger sold 15,051 shares for about $1.05 million. CFO Adam C. Spice and Senior Vice President Arjun Kampani also trimmed their positions, with Kampani's 7,754 shares going for between $69.53 and $71.17 apiece.

The transactions were structured as "sell-to-cover" exercises, a routine mechanism executives use to settle tax liabilities on vesting restricted stock units. It's a distinction that matters: these weren't discretionary bets against the company, but rather administrative necessities tied to compensation packages.

A Backlog That Keeps Compounding

The insider activity lands at a moment when Rocket Lab's operational cadence has rarely been busier. On August 20, the company completed its 93rd Electron mission from Launch Complex 1 in New Zealand, delivering a QPS-SAR Earth-observation satellite to orbit for the Institute for Q-shu Pioneers of Space. Two days earlier, Rocket Lab secured its place in the U.S. Space Force's NITE-STAR program — a framework valued at up to $981 million — along with entry into the Space Data Network Consortium and initial delivery orders worth $12 million for secure optical communications.

Just days before that, the first of 17 satellite platforms began its journey under a $143 million contract with MDA Space, built to support Globalstar's direct-to-device network. Viasat has also tapped Rocket Lab to construct a satellite bus based on the Lightning-GEO platform for a Space Force program.

That concentration of government work helps explain the numbers behind the company's second-quarter report, released August 10. Revenue came in at $234.07 million, up 62 percent year over year and ahead of the $231.62 million analysts had penciled in. The backlog swelled to a record $2.36 billion — a 137 percent jump from the prior year. The catch: the GAAP loss per share of $0.08 was wider than the $0.06 deficit the Street had expected.

Analysts Split Down the Middle

That gap between growth and profitability has produced sharply divergent views on Wall Street. On August 15, investment platform Wall Street Zen downgraded Rocket Lab from "Hold" to "Sell," citing valuation concerns and the insider sales despite the record quarter. The same day, Pluang raised its price target to $209 with a "Buy" rating, pointing to the revenue beat and faster-than-expected expansion of vertically integrated infrastructure.

Seeking Alpha added its voice on August 22, upgrading the stock to "Buy" on the strength of the improved risk-reward after the recent pullback and the ballooning backlog. The automated nature of some of these calls — Wall Street Zen's in particular — means they carry limited weight on their own, but the divergence underscores how much uncertainty surrounds the stock's valuation.

The Iridium Deal Looms Large

The bigger question mark is the proposed acquisition of Iridium Communications. The waiting period under the Hart-Scott-Rodino Act has expired, and Rocket Lab has filed its S-4 form along with FCC applications to transfer Iridium's licenses. Iridium shareholders are scheduled to vote on the merger on September 24.

To fund the deal, Rocket Lab plans to replace its existing bridge financing commitments with permanent debt and equity instruments, while renegotiating Iridium's current $1.775 billion credit facility. That strategy will likely increase the share count over time — a dilution overhang that helps explain some of the market's current caution.

A Chart That Tells Its Own Story

The stock closed Wednesday at €56.90, down 9.0 percent over the past week. It now sits roughly 18 percent below its 50-day moving average and well under the 200-day line, with the RSI at 35.3 pointing to an extended sell-off phase.

Investors will get their next read on the company when Rocket Lab reports third-quarter results on November 9. Management has guided for revenue between $250 million and $265 million — a range that will test whether the operational momentum can translate into sustained growth, or whether the skeptics have the better of the argument.

In the meantime, the company continues to push forward on multiple fronts, including the planned unveiling of the "GHOST" mobile launch system for Electron and HASTE rockets. Whether the insider sales were purely tax-driven routine or something more meaningful should become clearer once the Iridium financing structure takes shape and the Neutron rocket's debut, targeted for late 2026, draws closer.